The role of lactylation-mediated regulated cell death in acute central nervous system diseases

The dynamic equilibrium of regulated cell death (RCD) is crucial for maintaining homeostasis within the central nervous system (CNS); Dysregulation of lysine lactylation is linked to acute CNS injuries. This post-translational modification involves attaching a lactyl group to lysine residues. Enzyme-mediated lysine L-lactylation (KL-la) is the most studied form of lactylation in eukaryotes. KL-la influences gene transcription through histone lactylation and directly modulates protein function via non-histone lactylation, thereby playing a critical role in regulating various RCD subtypes. This review examines acute CNS diseases like stroke, traumatic brain injury, spinal cord injury, and hypoxic-ischemic encephalopathy, providing a detailed overview of L-lactate sources, KL-la landscape, and its links to RCD. For KL-la and RCD, site-directed mutagenesis or rescue experiments now provide causal evidence for various cell death types, such as apoptosis, pyroptosis, and others. Most evidence focuses on non-histone lactylation, with limited direct evidence for histone lactylation. The regulatory effects of KL-la vary by disease context and target protein. Validated non-histone sites are associated with mitochondrial homeostasis, indicating that mitochondrial quality control plays a key role in the regulation of various RCD subtypes by KL-la. In acute CNS diseases, L-lactate is derived mainly from astrocytes, microglia, and neurons, with no current evidence implicating oligodendrocytes. The KL-la landscape is unevenly distributed across diseases, with some studies indicating cell-type and site-specific patterns. Among the identified histone lactylation sites, H3K18La is the most frequently reported; however, its apparent prevalence may be influenced by detection biases associated with antibody accessibility. KL-la has a dual regulatory role in RCD during acute CNS diseases, with validated sites only on non-histone substrates and no direct evidence on histones. Research mainly targets neurons and the acute phase, leaving KL-la’s role in the inflammatory and repair phases largely unexplored. This review also explores the therapeutic potential of targeting lactate metabolism and lactylation in acute CNS diseases. It highlights that current strategies mainly validate specific KL-la sites’ functionality, not provide practical treatments. Future research should focus on unbiased identification and causal validation of KL-la sites and clarify D-lactylation’s role in these diseases.

Authors

Institutions

Publication Details

Journal
Frontiers in Cell and Developmental Biology
Published
2026-11-19
DOI
https://doi.org/10.3389/fcell.2026.1945652
Primary Topic
Cell death mechanisms and regulation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

The role of lactylation-mediated regulated cell death in acute central nervous system diseases

Da-ling Chen, Jia-Yang Xu, Jing Luo, Yun Hai-li et al.
Frontiers in Cell and Developmental Biology
Cell death mechanisms and regulation
article

The role of lactylation-mediated regulated cell death in acute central nervous system diseases

Da-ling Chen, Jia-Yang Xu, Jing Luo, Yun Hai-li, Yi Zhang, Xiaokang Zhang, Hua Jin, Yang Yu, Zheng-rong Zhang, Jun Peng
article en

Abstract

The dynamic equilibrium of regulated cell death (RCD) is crucial for maintaining homeostasis within the central nervous system (CNS); Dysregulation of lysine lactylation is linked to acute CNS injuries. This post-translational modification involves attaching a lactyl group to lysine residues. Enzyme-mediated lysine L-lactylation (KL-la) is the most studied form of lactylation in eukaryotes. KL-la influences gene transcription through histone lactylation and directly modulates protein function via non-histone lactylation, thereby playing a critical role in regulating various RCD subtypes. This review examines acute CNS diseases like stroke, traumatic brain injury, spinal cord injury, and hypoxic-ischemic encephalopathy, providing a detailed overview of L-lactate sources, KL-la landscape, and its links to RCD. For KL-la and RCD, site-directed mutagenesis or rescue experiments now provide causal evidence for various cell death types, such as apoptosis, pyroptosis, and others. Most evidence focuses on non-histone lactylation, with limited direct evidence for histone lactylation. The regulatory effects of KL-la vary by disease context and target protein. Validated non-histone sites are associated with mitochondrial homeostasis, indicating that mitochondrial quality control plays a key role in the regulation of various RCD subtypes by KL-la. In acute CNS diseases, L-lactate is derived mainly from astrocytes, microglia, and neurons, with no current evidence implicating oligodendrocytes. The KL-la landscape is unevenly distributed across diseases, with some studies indicating cell-type and site-specific patterns. Among the identified histone lactylation sites, H3K18La is the most frequently reported; however, its apparent prevalence may be influenced by detection biases associated with antibody accessibility. KL-la has a dual regulatory role in RCD during acute CNS diseases, with validated sites only on non-histone substrates and no direct evidence on histones. Research mainly targets neurons and the acute phase, leaving KL-la’s role in the inflammatory and repair phases largely unexplored. This review also explores the therapeutic potential of targeting lactate metabolism and lactylation in acute CNS diseases. It highlights that current strategies mainly validate specific KL-la sites’ functionality, not provide practical treatments. Future research should focus on unbiased identification and causal validation of KL-la sites and clarify D-lactylation’s role in these diseases.

Frontiers in Cell and Developmental BiologyVol. 14
Kunming University of Science and Technology (CN), First People's Hospital of Yunnan Province (CN), The First Hospital of Kunming (CN)
Cell death mechanisms and regulation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon